Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Inogen Inc before investing.
In this article, we go over a few key elements for understanding Inogen Inc’s stock price such as:
- Inogen Inc’s current stock price and volume
- Why Inogen Inc’s stock price changed recently
- Upgrades and downgrades for INGN from analysts
- INGN’s stock price momentum as measured by its relative strength
About Inogen Inc
(INGN)
Before we jump into Inogen Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.
Want to learn more about Inogen Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Inogen Inc.
What Caused Inogen Inc Stock’s Price to Dip?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 30, 2024, there were 2 analysts who downgraded Inogen Inc’s stock and 2 analysts who upgraded over the last month.
Additionally, you'll want to evaluate Inogen Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Inogen Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
Inogen Inc’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Inogen Inc
(INGN) by visiting AAII Stock Evaluator.
Relative Price Strength of Inogen Inc
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of August 30, 2024, Inogen Inc has a weighted four-quarter relative price strength of 17.61%, which translates to a Momentum Score of 93 and is considered to be Very Strong.
Want to learn more about how Inogen Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
Inogen Inc Stock Price: Bottom Line
As of September 3, 2024, Inogen Inc’s stock price is $11.68, which is down 4.81% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Inogen Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
Yield Screen: 8.7% Compared to S&P 500
at only 6.9%
Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.